Among the tested semaphorins, SEMA3B and SEMA3G mRNA levels proved to be a prognostic marker for OS in our cohort including 11 low-grade and 27 high-grade gliomas (P=0.029 and P=0.016, respectively) (Figure 2A and B). The gene discussed is SEMA3G; the disease is central nervous system cancer.